Order Article Reprints

Soltan MA, Alhanshani AA, Shati AA, Alqahtani YA, Alshaya DS, Alharthi J, Altalhi SA, Fayad E, Zaki MSA, Eid RA. Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome. Biomedicines. 2023; 11(8):2254. https://doi.org/10.3390/biomedicines11082254

Soltan, Mohamed A., Ahmad A. Alhanshani, Ayed A. Shati, Youssef A. Alqahtani, Dalal Sulaiman Alshaya, Jawaher Alharthi, Sarah Awwadh Altalhi, Eman Fayad, Mohamed Samir A. Zaki, and Refaat A. Eid. 2023. "Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome" Biomedicines 11, no. 8: 2254. https://doi.org/10.3390/biomedicines11082254

Soltan, M. A., Alhanshani, A. A., Shati, A. A., Alqahtani, Y. A., Alshaya, D. S., Alharthi, J., Altalhi, S. A., Fayad, E., Zaki, M. S. A., & Eid, R. A. (2023). Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome. Biomedicines, 11(8), 2254. https://doi.org/10.3390/biomedicines11082254